FDA
-
-
-
-
-
-
-
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
-
-
-
-
-
-
-
NeuroOne® Issues Letter to Shareholders
-
-
-
-
-
-
-
NeuroOne Medical (NMTC) Regains Compliance with Nasdaq Listing Requirements
-
-
-
-
-
-
-
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
-
-
-
-
-
-
-
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
-
-
-
-
-
-
-
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

